Midazolam vs Yttrium Y 90 Ibritumomab Tiuxetan
Midazolam vs Yttrium Y 90 Ibritumomab Tiuxetan: Overview
This comparison examines the pharmacological differences between Midazolam and Yttrium Y 90 Ibritumomab Tiuxetan.
Mechanism of Action
Midazolam: Ultra-short-acting benzodiazepine GABA-A receptor positive allosteric modulator.
Pharmacokinetics
Half-life: Midazolam — 1.5-2.5 hours.
Chemical Properties
Molecular Formula: Midazolam — C18H13ClFN3.
Molecular Weight: Midazolam — 325.7670 g/mol.
Type: Midazolam — Small molecule; Yttrium Y 90 Ibritumomab Tiuxetan — Antibody.